Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

Bioequivalency Clinical Trial

Official title:
Randomized, Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

Status Completed

Clinical Trial Summary

The objective of this study is to compare the rate and extent of absorption of bicalutamide 50 mg tablet (test) versus Casodex (reference), administered as 1 x 50 mg tablet under fasting conditions

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Bioequivalency

Clinical Trial Details

NCT number	NCT01039233
Study type	Interventional
Source	Kremers Urban Development Company
Contact
Status	Completed
Phase	Phase 1
Start date	May 2005
Completion date	July 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05665283` - A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions	Phase 1
Unknown status	`NCT01227811` - Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.	Phase 1
Completed	`NCT00803946` - Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fed Conditions	Phase 1
Completed	`NCT00803764` - Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions	Phase 1
Completed	`NCT00804401` - Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions	Phase 1
Completed	`NCT00804440` - Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions	Phase 1
Unknown status	`NCT01229280` - Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.	Phase 1